Crucell Switzerland (Vivotif Operations)
M&A
STATUS
71-80
EMPLOYEES
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Provider of travel vaccines. The unit manufactures and distributes travel vaccines for typhoid and hepatitis A.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
- Switzerland
Crucell Switzerland (Vivotif Operations) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Crucell Switzerland (Vivotif Operations)‘s full profile, request access.
Request full access to PitchBookCrucell Switzerland (Vivotif Operations) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Crucell Switzerland (Vivotif Operations)‘s full profile, request access.
Request full access to PitchBook